SARS-CoV-2 vaccination with CoronaVac: seroconversion rate in healthcare workers after 40 days
Explore this paper's citation graph
Summary
The seroconversion rate of the CoronaVac vaccine in healthcare workers (HCWs) 40 days after administration showed that CoronaVac has a high seroconversion rate when evaluated in an HCW population.
- Type
- article
- Published
- 2021-04-30
- Cited by
- 22
- References
- 29
- Access
- Open access
- OpenAlex
- https://openalex.org/W3159427996
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:242983123
Keywords
Seroconversion, Healthcare worker, Health care, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Vaccination
References
- Memory B cells
- Suppression of normal immune responses after treatment with rituximab
- Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
- PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase
- Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
- Biochemical characterization of SARS-CoV-2 nucleocapsid protein
- The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa
- Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
- Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020
- Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay
- Single-domain antibodies make a difference
- Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees.
- Comparative Assessment of Sera from Individuals after S-Gene RNA-Based SARS-CoV-2 Vaccination with Spike-Protein-Based and Nucleocapsid-Based Serological Assays
- Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
- Immunity to SARS-CoV-2: Lessons Learned
- Prioritizing COVID-19 vaccination by age
Cited by
- Study on the mucosal and serological immune response to the Novel Coronavirus (SARS-CoV-2) vaccine
- Safety and Immunogenicity of CoronaVac and ChAdOx1 Against the SARS-CoV-2 Circulating Variants of Concern (Alpha, Delta, Beta) in Thai Healthcare Workers
- SARS-CoV-2 seroprevalence and antibody trends in vaccinated, multi-ethnic healthcare employees.
- Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required
- COVID-19 Pneumonia After SARS-CoV-2 Vaccination with CoronaVac: A Case Series from Turkey
- Antibody response following a Comirnaty booster dose in CoronaVac vaccinated individuals.
- On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination
- Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey
- Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
- Populational analysis of the immunoglobulin G response to different COVID-19 vaccines in Brazil
- Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies
- Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population
- Population-Based Analysis of the Immunoglobulin G Response to Different COVID-19 Vaccines in Brazil
- Humoral Immune Response to CoronaVac in Turkish Adults
- IgA antibody dynamics in healthcare workers after CoronaVac® vaccination and heterologous Comirnaty® booster dose
- SARS CoV-2 infection among Healthcare Workers from different public health units in Brazil.
- A BOOSTER DOSE OF SARS-CoV-2 VACCINE IMPROVES SUBOPTIMAL SEROCONVERSION RATES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE. RESULTS OF A PROSPECTIVE MULTICENTER STUDY OF GETECCU (VACOVEII STUDY).
- Implementing a provisional overarching intervention for COVID-19 monitoring and control in the Brazil-Colombia-Peru frontier
- Assessment of immune responses to a Comirnaty® booster following CoronaVac® vaccination in healthcare workers
- Symptomatology and IgG Levels before and after SARS-CoV-2 Omicron Breakthrough Infections in Vaccinated Individuals
Related papers
- ОПЫТ ИССЛЕДОВАНИЯ СЕРОПРЕВАЛЕНТНОСТИ К ВИРУСУ SARS-CoV-2 НАСЕЛЕНИЯ ИРКУТСКОЙ ОБЛАСТИ В ПЕРИОД ВСПЫШКИ COVID-19
- Перинатальные последствия COVID-19 (SARS-CoV-2): обзор литературы (часть I)
- ОПЫТ ОЦЕНКИ ПОПУЛЯЦИОНОГО ИММУНИТЕТА К SARS-CoV-2 СРЕДИ НАСЕЛЕНИЯ ЛЕНИНГРАДСКОЙ ОБЛАСТИ В ПЕРИОД ЭПИДЕМИИ COVID-19
- Особенности сахароснижающей фармакотерапии у пациентов с SARS-CoV-2 (COVID-19)
- ПОПУЛЯЦИОННЫЙ ИММУНИТЕТ К ВИРУСУ SARS-CoV-2 СРЕДИ НАСЕЛЕНИЯ САНКТ-ПЕТЕРБУРГА В АКТИВНУЮ ФАЗУ ЭПИДЕМИИ COVID-19
- Частота выявления SARS-CoV-2 в фекалиях детей с инфекционными диареями в дебюте эпидемии COVID-19
- Спонтанний пневмоторакс у хворих на нову коронавірусну хворобу SARS-CoV-2 COVID-19
- COVID-19 – особенности течения у беременных женщин и детей младше 1 года
- ИНФЕКЦИЯ SARS-COV-2 (COVID-19): ПОЗИЦИЯ ГАБОНСКОЙ ТРАДИЦИОННОЙ ФАРМАКОПЕИ